Solara Active Pharma Sciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
For the nine months, the company reported sales was INR 10,262.8 million compared to INR 10,631.9 million a year ago. Revenue was INR 10,299.5 million compared to INR 10,810.6 million a year ago. Net loss was INR 3,120.5 million compared to INR 259.4 million a year ago. Basic loss per share from continuing operations was INR 86.69. Diluted loss per share from continuing operations was INR 86.69 compared to INR 7.21 a year ago.